Lighting Solomon’s Future with Stem Cell Therapy

Solomon, my Son with a powerful name and a face full of kindness and hope is diagnosed with Atypical Autism.

My Pain. My Hope. My Proud. My LOVE.

In March 2024, our son, Solomon, was diagnosed with Non-Verbal

Autism, but we start understand that our child is special one 2 years before. Some of the things we noticed were, he lost his ability to use sign language, he wouldn’t respond to his name anymore, he wouldn’t look at us, and he lost stability in his core, among other things.

Additionally, he has gut issues (leaky gut, gut dysbiosis, yeast overgrowth, etc), methylation Issues (inability to detoxify at the cellular level), constant inflammation in his brain and hypotonia (low muscle tone). Over the last few years, Solo has made great progress through multiple biomedical interventions along with occupational and behavior therapy. We have noticed him “coming back to our world” slowly but surely.

But, there is still much more progress to be made. Each year that goes by, he will fall further behind his peers unless we do more. We have decided to try and jump into the next step of his journey, and are asking friends and family (or anyone who might be touched by Solomon’s story) who would like to help, to please make a tax-deductible donation to pay for this potentially life-changing therapy.

About the treatment (from the facility we will take him for the treatment):

Stem Cell Therapy for Autism

What is Autism?

Autism is a spectrum of disorders characterized by marked abnormalities in communication and social interactions. Two common consistent findings are associated in children with this disorder are diminished oxygenation in specific areas of the brain and a chronic immunologically mediated inflammatory condition in the gut.

What is the scientific rationale behind using stem cells to treat autism?

Current investigative therapies for autism attempt to reverse these abnormalities through administration of antibiotics, anti‐inflammatory agents, and hyperbaric oxygen. Unfortunately, none of these approaches address the root causes of oxygen deprivation and intestinal inflammation.

The rationale behind treating autism with umbilical cord tissue-derived mesenchymal stem cells is that autism, and its degree of severity, has been significantly correlated with inflammatory and neuro-inflammatory cytokines including macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC). Intravenous administration of umbilical cord MSCs has been shown in multiple clinical trials to decrease inflammation. Decreasing inflammation in the autistic patient may alleviate symptoms of autism.

Through administration of mesenchymal stem cells, we have observed improvement in patients treated at our facilities.

In many cases, children are losing their diagnoses after just one round of therapy.